RE:RE:RE:Holding longThe questions and rumors that we still need data from Aspire have been circulating on CEO.ca and elsewhere for a while now and if we had what we needed he could have dispelled that bad info easily but has not. and even when i directly questioned him about it in the agm, i got an answer describing the source data verification procedure so I'm fully expecting in August to hear that we can not complete the trial analysis due to missing base info or something like that. It just sucks and I get that management is in a very tough spot and theyre doing what they can but they have completely lost investors faith and we need to know all the risks instead of the rosy outlook we've been getting. The way I see it is we will have to conclude the lawsuits in order to even see if ACP is effective and that there is no moving forward in any way until a judgement is made. It will become a battle of attrition between Aspire and Hemostemix and whoever can pay their lawyers more and for a longer period of time will win the rights to the data and the tech. The delaware case has Aspire on the defense but the Florida case docs show that Aspire may actually have sole ownership of the technology. It's complex and I'm not a lawyer but that case is not a done deal as Smeenk has been saying. I see a long dark road ahead for hemostemix and they probably won't be able to suck any more capital out of investors until they can shed some of the risk. Im already down 70% so I'm here until the bitter end. Good luck fellow idiots. Lol